Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2022-08-26 AGM Information
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
无锡祥生医疗科技股份有限公司2022年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as the "2022 First Extraordinary General Meeting (EGM) Meeting Materials" of Wuxi Xiangsheng Medical Technology Co., Ltd. It contains detailed meeting instructions, agenda, and proposed resolutions including changes to registered capital and amendments to the company articles of association. The content is focused on the preparation and conduct of a shareholders' meeting, including voting procedures and legal compliance. There is no financial data or earnings information, nor is it a transcript or announcement of results. It is not a proxy solicitation or remuneration report. The document is a set of materials provided for a shareholders' meeting, which fits the definition of AGM Information (AGM-R), even though it is an extraordinary meeting, the category covers meeting materials. The document length is substantial and contains the full meeting materials, not just an announcement of the meeting or results, so it is not RPA or DVA. Therefore, the best classification is AGM Information (AGM-R).
2022-08-26 Chinese
国金证券股份有限公司关于无锡祥生医疗科技股份有限公司2022年半年度持续督导跟踪报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2022 年半年度持续督导跟踪报告" which translates to "2022 Semi-Annual Continuous Supervision Follow-up Report" issued by Guojin Securities Co., Ltd. as the sponsor institution for Wuxi Xiangsheng Medical Technology Co., Ltd. The content includes detailed supervisory activities, risk factors, financial data for the first half of 2022, and compliance with regulations. It is a comprehensive report covering a half-year period with substantive financial data and management discussion. The document is not an announcement of a report but the report itself, and it is not a full annual report (10-K) but an interim/quarterly type report covering half-year data. Therefore, the most appropriate classification is Interim / Quarterly Report (IR). H1 2022
2022-08-22 Chinese
无锡祥生医疗科技股份有限公司2022年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2022 年半年度报告" which translates to "2022 Half-Year Report". It contains detailed financial data, management discussion and analysis, company overview, accounting data, and financial indicators for the period January to June 2022. The document is comprehensive, with 160 pages and about 15,000 characters, indicating it is a full report rather than a brief announcement. The content includes financial statements, management analysis, and other substantive financial information typical of an interim or quarterly report. The document explicitly states it is a half-year report and includes unaudited financial data for the first half of 2022. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-19 Chinese
无锡祥生医疗科技股份有限公司2022年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2022 半年度报告摘要' which translates to '2022 Half-Year Report Summary'. It contains detailed financial data such as total assets, net profit, earnings per share, and shareholder information for the half-year period. The document explicitly states it is a summary of the half-year report and advises investors to read the full half-year report for comprehensive information. The length is 3909 characters, which is relatively short but contains substantive financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or a certification, but contains actual financial figures and analysis. Therefore, the correct classification is IR with high confidence. H1 2022
2022-08-19 Chinese
祥生医疗第二董事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board of directors meeting of Wuxi Xiangsheng Medical Technology Co., Ltd. It includes multiple agenda items such as approval of the 2022 semi-annual report, fundraising usage report, adjustments to stock incentive plans, capital changes, and scheduling of a shareholders meeting. The document is titled as a board meeting resolution announcement and contains voting results for each agenda item. It does not contain the full semi-annual report or financial statements but references that the full reports are published separately on the stock exchange website. The document is not a full financial report but a formal announcement of board decisions and meeting outcomes. Therefore, it fits the category of Board/Management Information (MANG). The document length is under 5,000 characters, but it is not merely a report publication announcement; it contains substantive board meeting resolutions and voting results, which aligns with MANG rather than RPA or RNS.
2022-08-19 Chinese
祥生医疗第二届监事会第十三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Wuxi Xiangsheng Medical Technology Co., Ltd. It details the approval of various proposals related to the 2022 semi-annual report, fundraising usage, and adjustments to the 2021 restricted stock incentive plan. The document references the 2022 semi-annual report and other related announcements but does not contain the actual financial statements or detailed report content itself. The document length is 2521 characters, which is relatively short and mainly serves as an official announcement of meeting resolutions and approvals. Therefore, it is not the semi-annual report itself but an announcement related to it. This fits best with the category of Regulatory Filings (RNS), as it is a general regulatory announcement about supervisory board resolutions and approvals without substantive financial data or full report content.
2022-08-19 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.